Oxford BioDynamics plc
TR-1 |
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | OXFORD BIODYNAMICS PLC |
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) | |
Non-UK issuer |
2. Reason for the notification (please mark the appropriate box or boxes with an "X") | |
An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments | |
An event changing the breakdown of voting rights | |
Other (please specify) iii: |
3. Details of person subject to the notification obligation | |
Name | Arbuthnot Latham (Nominees) Limited |
City and country of registered office (if applicable) | London, United Kingdom |
4. Full name of shareholder(s) (if different from 3.) |
Name |
City and country of registered office (if applicable) |
5. Date on which the threshold was crossed or reached: | 03/11/2023 |
6. Date on which issuer notified (DD/MM/YYYY): | 06/11/2023 |
7. Total positions of person(s) subject to the notification obligation | ||||
| % of voting rights at-tached to shares | % of voting rights through financial instruments | Total of both in % | Total number of voting rights held in issuer |
Resulting situation on the date on which threshold was crossed or reached | 9.13% | | 9.13% | 18,462,235 |
| Position of previous notification (if applicable) |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached | ||||
A: Voting rights attached to shares | ||||
Class/type of shares ISIN code (if possible) | Number of voting rights | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
GB00BD5H8572 | | 18,462,235 | | 9.13% |
| |
| |
|
SUBTOTAL 8. A | 18,462,235 | 9.13% |
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") | ||||
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer | X | |||
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) | | |||
Name xv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial | Total of both if it equals or is higher than the notifiable threshold | |
|
|
|
| |
10. In case of proxy voting, please identify: | |
Name of the proxy holder | |
The number and % of voting rights held | |
The date until which the voting rights will be held | |
11. Additional information |
Based on total voting rights of 202,303,415 |
Place of completion | London |
Date of completion | 06/11/23 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.